World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
12894
World Ranking
2704
National Ranking
1289

Steven W. Dow publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Steven W. Dow sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 232 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Steven W. Dow D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Steven W. Dow sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Steven W. Dow is affiliated with Colorado State University in the United States. Their research spans primarily the fields of Medicine, Biochemistry, Genetics and Molecular Biology, with a focus on Immunology and Microbiology. Within these broader fields, notable subfields include Immunology, Genetics, Surgery, Molecular Biology, and Pulmonary and Respiratory Medicine.

The scientist's work covers a range of topics, particularly in veterinary and immunological research. Key areas of focus include mesenchymal stem cell research, virus-based gene therapy research, immunotherapy and immune responses, veterinary oncology research, osteoarthritis treatment and mechanisms, immune response and inflammation, and veterinary equine medical research.

Recent publications demonstrate active involvement in oncology and immunotherapy, often intersecting with veterinary medicine. Some significant papers include:

  • "Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats," 2021, Veterinary and Comparative Oncology
  • "Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors," 2022, Nature Communications
  • "A Role for Dogs in Advancing Cancer Immunotherapy Research," 2020, Frontiers in Immunology
  • "Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma," 2021, Clinical Cancer Research
  • "A single-cell RNA sequencing atlas of circulating leukocytes from healthy and osteosarcoma affected dogs," 2023, Frontiers in Immunology

Steven W. Dow has collaborated frequently with a number of researchers, indicating ongoing cooperative projects and shared scientific interests. Frequent co-authors include Lyndah Chow, Lynn M. Pezzanite, Laurie R. Goodrich, Jade Kurihara, and Dylan T. Ammons.

The scientist has published extensively in several journals, reflecting a strong presence in veterinary and comparative research. Frequent publication venues include Frontiers in Veterinary Science, Animals, Equine Veterinary Journal, Annals of Translational Medicine, and Veterinary and Comparative Oncology.

In addition to articles, Steven W. Dow has contributed to book publications. One example is a title published by Frontiers Media: "Canine Melanoma in Comparative Oncology: Translate Research Advances to Develop New Diagnostic and Therapeutic Options" from 2023.

Best Publications

  • Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation.

    Genevieve P Hartley;Lyndah Chow;Dylan T Ammons;William H Wheat

  • Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously.

    Steven W. Dow;Lee G. Fradkin;Denny H. Liggitt;Andy P. Willson

  • Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes.

    Karen Zaks;Michael Jordan;Amanda Guth;Karen Sellins

  • Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns.

    D L Sodora;E G Shpaer;B E Kitchell;S W Dow

  • Lung environment determines unique phenotype of alveolar macrophages

    Amanda Michele Guth;William J. Janssen;Catherine M. Bosio;Erika C. Crouch

  • Feline immunodeficiency virus: a neurotropic lentivirus.

    Steven W. Dow;Mary L. Poss;Edward A. Hoover

  • Dietary Selenium Modulates Activation and Differentiation of CD4+ T Cells in Mice through a Mechanism Involving Cellular Free Thiols

    FuKun W. Hoffmann;Ann C. Hashimoto;Leigh Anne Shafer;Steven Dow

  • Francisella tularensis Induces Aberrant Activation of Pulmonary Dendritic Cells

    Catharine M. Bosio;Steven W. Dow

  • Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer

    B.J. Biller;R.E. Elmslie;R.C. Burnett;A.C. Avery

  • Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose‐Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model

    Sirikul Soontararak;Lyndah Chow;Valerie Johnson;Jonathan Coy

  • Metronomic Therapy with Cyclophosphamide and Piroxicam Effectively Delays Tumor Recurrence in Dogs with Incompletely Resected Soft Tissue Sarcomas

    R.E. Elmslie;P. Glawe;S.W. Dow

  • Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.

    Susan Lana;Lance U'ren;Susan Plaza;Robyn Elmslie

  • Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors

    Unknown

  • Liposome-siRNA-Peptide Complexes Cross the Blood-Brain Barrier and Significantly Decrease PrPC on Neuronal Cells and PrPRES in Infected Cell Cultures

    Bruce Pulford;Natalia Reim;Aimee Bell;Jessica Veatch

  • Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines

    Rachel H. McMahan;Jennifer A. McWilliams;Kimberly R. Jordan;Steven W. Dow

  • Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats.

    Amy K. LeBlanc;Matthew Atherton;R. Timothy Bentley;C. Elizabeth Boudreau

  • Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies

    Jessica M Quimby;Tracy L Webb;Lauren M Habenicht;Steven W Dow

  • In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.

    S W Dow;R E Elmslie;A P Willson;L Roche

  • Antibacterial activity of human mesenchymal stem cells mediated directly by constitutively secreted factors and indirectly by activation of innate immune effector cells.

    Lyndah Chow;Valerie Johnson;Renata Impastato;Jonathan Coy

  • Present and future therapeutic strategies for melioidosis and glanders.

    D Mark Estes;Steven W Dow;Herbert P Schweizer;Alfredo G Torres

  • Activated Mesenchymal Stem Cells Interact with Antibiotics and Host Innate Immune Responses to Control Chronic Bacterial Infections.

    Valerie Johnson;Tracy Webb;Annalis Norman;Jonathan Coy

  • A Burkholderia pseudomallei ΔpurM Mutant Is Avirulent in Immunocompetent and Immunodeficient Animals: Candidate Strain for Exclusion from Select-Agent Lists

    Katie L. Propst;Takehiko Mima;Kyoung Hee Choi;Steven W. Dow

  • Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma.

    Jenna H Burton;L. Mitchell;D. H. Thamm;S. W. Dow

  • Management of Anaerobic Infections

    Steven W. Dow

Frequent Co-Authors

Michael R. Lappin
Michael R. Lappin Colorado State University
Herbert P. Schweizer
Herbert P. Schweizer Colorado State University
Edward A. Hoover
Edward A. Hoover Colorado State University
Erwin W. Gelfand
Erwin W. Gelfand University of Colorado Anschutz Medical Campus
Ross M. Kedl
Ross M. Kedl University of Colorado Boulder
Helle Bielefeldt-Ohmann
Helle Bielefeldt-Ohmann University of Queensland
Paul S. Morley
Paul S. Morley Texas A&M University
Katsuyuki Takeda
Katsuyuki Takeda National Jewish Health
Stephen J. Withrow
Stephen J. Withrow Colorado State University
Jaime F. Modiano
Jaime F. Modiano University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees can broaden career opportunities in healthcare and research. Nursing programs, for example, often provide foundational knowledge that complements immunological expertise. Many students consider the easiest accelerated nursing programs to get into as an efficient pathway to enter the nursing field while building clinical skills related to immune system disorders.

Similarly, practical nursing roles remain in demand, and the lpn programs easy to get into offer flexible, accessible options for those seeking quicker entry into patient care environments. These programs often serve as stepping stones toward advanced specializations.

For professionals aiming to advance their careers with clinical responsibilities, the easiest np program opportunities can provide streamlined paths to becoming nurse practitioners, many of whom specialize in immunology-related areas such as infectious disease or allergy and immunology clinics.

Moreover, mental health intersects with immunology through psychoneuroimmunology research and practice. The best online pmhnp programs offer psychiatric-mental health nurse practitioner training with strong clinical placement rates, preparing graduates to address complex immune-related aspects of mental health disorders.

Best Scientists Citing Steven W. Dow

Trending Scientists

Recently Published Articles